Share-based Payment Arrangement, Expense of TREACE MEDICAL CONCEPTS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TREACE MEDICAL CONCEPTS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • TREACE MEDICAL CONCEPTS, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $7,555,000, a 12% decline year-over-year.
  • TREACE MEDICAL CONCEPTS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $33,823,000, a 11% increase year-over-year.
  • TREACE MEDICAL CONCEPTS, INC. annual Share-based Payment Arrangement, Expense for 2025 was $33,823,000, a 11% increase from 2024.
  • TREACE MEDICAL CONCEPTS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $30,603,000, a 76% increase from 2023.
  • TREACE MEDICAL CONCEPTS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $17,352,000, a 114% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

TREACE MEDICAL CONCEPTS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $33,823,000 $7,555,000 -$1,000,000 -12% 01 Oct 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $34,823,000 $7,998,000 +$98,000 +1.2% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $34,725,000 $9,577,000 +$2,837,000 +42% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $31,888,000 $8,693,000 +$1,285,000 +17% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $30,603,000 $8,555,000 +$2,683,000 +46% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $27,920,000 $7,900,000 +$2,708,000 +52% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $25,212,000 $6,740,000 +$3,144,000 +87% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $22,068,000 $7,408,000 +$4,716,000 +175% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $17,352,000 $5,872,000 +$3,402,000 +138% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
Q3 2023 $13,950,000 $5,192,000 +$2,923,000 +129% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $11,027,000 $3,596,000 +$1,633,000 +83% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $9,394,000 $2,692,000 +$1,283,000 +91% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $8,111,000 $2,470,000 +$1,177,000 +91% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $6,934,000 $2,269,000 +$1,430,000 +170% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $5,504,000 $1,963,000 +$1,088,000 +124% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $4,416,000 $1,409,000 +$1,007,000 +250% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $3,409,000 $1,293,000 +$956,000 +284% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q3 2021 $2,453,000 $839,000 +$714,000 +571% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $1,739,000 $875,000 +$627,000 +253% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $1,112,000 $402,000 +$193,000 +92% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $919,000 $337,000 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2023 2022 FY
Q3 2020 $125,000 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $248,000 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $209,000 01 Jan 2020 31 Mar 2020 10-Q 25 May 2021 2021 Q1

TREACE MEDICAL CONCEPTS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $33,823,000 +$3,220,000 +11% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $30,603,000 +$13,251,000 +76% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $17,352,000 +$9,241,000 +114% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2026 2025 FY
2022 $8,111,000 +$4,702,000 +138% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $3,409,000 +$2,490,000 +271% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $919,000 +$104,000 +13% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2023 2022 FY
2019 $815,000 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.